Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2000-05-10
2004-11-30
Celsa, Bennett (Department: 1639)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S287100, C435S287200, C435S288400, C436S501000, C436S518000, C436S809000
Reexamination Certificate
active
06824987
ABSTRACT:
BACKGROUND OF THE INVENTION
The ability to identify small molecule ligands for any protein of interest has far-reaching implications, both for the elucidation of protein function and for the development of novel pharmaceuticals. With the introduction of split-pool strategies for synthesis (Furka et al.,
Int. J. Pept. Protein Res.
1991, 37, 487; Lam et al.,
Nature
1991, 354, 82; each of which is incorporated herein by reference) and the development of appropriate tagging technologies (Nestler et al.,
J. Org. Chem.
1994, 59, 4723; incorporated herein by reference), chemists are now able to prepare large collections of natural product-like compounds immobilized on polymeric synthesis beads (Tan et al.,
J. Am. Chem. Soc.
1998, 120, 8565; incorporated herein by reference). These libraries provide a rich source of molecules for the discovery of new protein ligands.
With such libraries in hand, the availability of efficient methods for screening these compounds becomes imperative. One method that has been used extensively is the on-bead binding assay (Lam et al.,
Chem. Rev.
1997, 97, 411; incorporated herein by reference). An appropriately tagged protein of interest is mixed with the library and beads displaying cognate ligands are subsequently identified by a chromagenic or fluorescence-linked assay (Kapoor et al.,
J. Am. Chem. Soc.
1998, 120, 23; Morken et al.,
J. Am. Chem. Soc.
1998, 120, 30; St. Hilare et al.,
J. Am. Chem. Soc.
1998, 120, 13312; incorporated herein by reference). Despite the proven utility of this approach, it is limited by the small number of proteins that can be screened efficiently. In principle, the beads can be stripped of one protein and reprobed with another; however, this serial process is slow and limited to only a few iterations. In order to identify a specific small molecule ligand for every protein in a cell, tissue, or organism, high-throughput assays that enable each compound to be screened against many different proteins in a parallel fashion are required. Although Brown et al. (U.S. Pat. No. 5,807,522; incorporated herein by reference) have developed an apparatus and a method for forming high density arrays of biological macromolecules for large scale hybridization assays in numerous genetic applications, including genetic and physical mapping of genomes, monitoring of gene expression, DNA sequencing, genetic diagnosis, genotyping and distribution of reagents to researchers, the development of a high density array of natural product-like compounds for high-throughput screening has not been achieved.
Clearly, it would be desirable to develop methods for generating high density arrays that would enable the screening of compounds present in increasingly complex natural product-like combinatorial libraries in a high-throughput fashion to identify small molecule partners for biological macromolecules of interest.
SUMMARY OF THE INVENTION
The present invention provides compositions and methods to facilitate the high-throughput screening of compounds for the identification of desirable properties or interactions. In a preferred embodiment, the present invention provides compositions and methods to facilitate the identification of compounds that are capable of interacting with a biological macromolecule of interest. In one aspect, a composition is provided that comprises an array of more than one type of chemical compounds attached to a solid support, wherein the density of the array of compounds comprises at least 1000 spots per cm
2
, more preferably at least 5000 spots per cm
2
, and most preferably at least 10,000 spots per cm
2
. In another aspect, a composition is provided that comprises a plurality of one or more types of non-oligomeric chemical compounds attached to a glass or polymer support, wherein the density of the array of compounds comprises at least 1000 spots per cm
2
. In a particularly preferred embodiment, the chemical compounds are non-peptidic and non-oligomeric. In particularly preferred embodiments, these compounds are attached to the solid support through a covalent interaction. In another particularly preferred embodiment, small molecules are attached to the solid support through a covalent interaction. In a particularly preferred embodiment, the compounds are attached to the solid support using a Michael addition reaction. In another preferred embodiment, the compounds are attached to the solid support using a silylation reaction. In general, these inventive arrays are generated by: (1) providing a solid support, wherein said solid support is functionalized with a selected chemical moiety capable of interacting with a desired chemical compound to form an attachment; (2) providing one or more solutions of one or more types of compounds to be attached to the solid support; and (3) delivering said one or more types of compounds to the solid support whereby an array of compounds is generated and the array comprises a density of at least 1000 spots per cm
2
(FIG.
1
). In other embodiments, the array comprises a density of at least 5000 stops per cm
2
, and more preferably at least 10,000 spots per cm
2
.
In another aspect, the present invention provides methods for utilizing these arrays to identify small molecule partners for biological macromolecules (e.g., proteins, peptides, polynucleotides) of interest comprising: (1) providing an array of one or more types of compounds (e.g., more preferably, small molecules), wherein the array has a density comprising at least 1000 spots per cm
2
; (2) contacting the array with one or more types of biological macromolecules of interest; and (3) determining the interaction of specific small molecule-biological macromolecule partners (FIG.
1
). In particularly preferred embodiments, the biological macromolecules of interest comprise a collection of one or more recombinant proteins. In another preferred embodiment, the biological macromolecules of interest comprise a collection of macromolecules from a cell lysate. In another preferred embodiment, the biological macromolecules of interest comprise a polynucleotide.
DEFINITIONS
Unless indicated otherwise, the terms defined below have the following meanings:
“Antiligand”: As used herein, the term “antiligand” refers to the opposite member of a ligand/anti-ligand binding pair. The anti-ligand may be, for example, a protein or other macromolecule receptor in an effector/receptor binding pair.
“Compound”: The term “compound” or “chemical compound” as used herein can include organometallic compounds, organic compounds, metals, transitional metal complexes, and small molecules. In certain preferred embodiments, polynucleotides are excluded from the definition of compounds. In other preferred embodiments, polynucleotides and peptides are excluded from the definition of compounds. In a particularly preferred embodiment, the term compounds refers to small molecules (e.g., preferably, non-peptidic and non-oligomeric) and excludes peptides, polynucleotides, transition metal complexes, metals, and organometallic compounds.
“Ligand”: As used herein, the term “ligand” refers to one member of a ligand/anti-ligand binding pair, and is referred to herein also as “small molecule”. The ligand or small molecule may be, for example, an effector molecule in an effector/receptor binding pair.
“Michael Addition”: The term “Michael addition” refers to the reaction in which compounds containing electron-rich groups (e.g, groups containing sulfur, nitrogen, oxygen, or a carbanion) add, in the presence of base, to olefins of the from C=C—Z (including quinones), where Z is an electron-withdrawing group, such as aldehydes, ketones, esters, amides, nitriles, NO
2
, SOR, SO
2
R, etc.
“Microarray”: As used herein, the term “microarray” is a regular array of regions, preferably spots of small molecule compounds, having a density of discrete regions of at least about 1000/cm
2
.
“Natural Product-Like Compound”: As used herein, the term “natural product-like compound” refers to compounds that are similar to complex natural products which nature has selecte
Depew Kristopher M.
Hergenrother Paul
Koehler Angela N.
MacBeath Gavin
Schreiber Stuart L.
Baker C. Hunter
Celsa Bennett
Choate Hall & Stewart
Herschback Jarrell Brenda
President and Fellows of Harvard College
LandOfFree
Small molecule printing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Small molecule printing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Small molecule printing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3317777